Asian Sovereign Wealth Fund Invests in RNA Targeting Gene Therapy Startup
Posted on 05/22/2019
San Diego-based Locana, Inc. is a RNA-targeting gene therapy company that was formed in 2016. Locana raised US$ 55 million in a Series A financing led by ARCH Venture Partners with participation from Temasek Holdings and Lightstone Ventures, all existing investors. New investors include UCB Ventures and GV (formerly Google Ventures). Proceeds will be used […]
